- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT02745158
Registro delle connessioni della fibrodisplasia ossificante progressiva (FOP).
Connessione FOP: un registro globale per la comunità della fibrodisplasia ossificante progressiva
The Fibrodysplasia Ossificans Progressiva (FOP) Registry is a global, non-interventional, voluntary database that captures demographic and disease data directly from FOP patients and their caregivers via a secure, web-based patient portal. A physician portal (in development) will allow physicians to enter clinical data about their patients. The objectives are to organize the international FOP community for participation in clinical trials; to enable FOP patients worldwide to report data in a shared forum; to improve the collective understanding of FOP natural history; and to advance the understanding of FOP treatment outcomes.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
The FOP Registry is a global, non-interventional, voluntary database that captures demographic and disease data directly from FOP patients and their caregivers via a secure, web-based patient portal. No experimental intervention is involved. The objectives are to organize the international FOP community for participation in clinical trials; to enable FOP patients worldwide to report data in a shared forum; to improve the collective understanding of FOP natural history; and to advance the understanding of FOP treatment outcomes.
The Registry collects data through two sources. First, the Patient Portal (launched in July 2015) allows FOP patients and caregivers to enter information about their experiences living with FOP. Second, the Physician Portal (in development) will allow physicians to enter clinical data about patients under their care. The Registry will be capable of including data on specific marketed therapies under the direction and control of a sponsoring pharmaceutical company. Key identifiers will link the physician-reported data with the Patient Portal data.
Participants must have a confirmed diagnosis of FOP and the participant (or a parent or legal guardian) must be willing and able to provide written informed consent. There are no exclusion criteria. Data collected in the Patient Portal include: patient demographics and diagnosis pathway; medical and dental care; clinical research participation and biospecimen donation; heterotopic ossification (bone growth and episodic flare-ups); other signs and symptoms by body system; patient-reported outcomes (physical functioning, pain, fatigue, and general health); and assistive devices, aids, attendants, and adaptations. Because the Registry is designed to accommodate participants along a broad spectrum of FOP disease severity, most of the data fields are optional, allowing participants a high degree of flexibility in how much information they contribute, which also minimizes participant burden.
After completing the informed consent, participants enter their baseline (historical) data. Participants will be encouraged to update their information at least twice per year. Participants may withdraw their consent at any time without prejudice or providing an explanation. The Registry has no pre-specified end date and will continue for as long as it is sustainable and useful to the FOP community.
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Sammi Kile, MS
- Numero di telefono: 1-720-341-6999
- Email: registry@ifopa.org
Backup dei contatti dello studio
- Nome: Mark Hamilton, PhD
- Numero di telefono: 1-203-605-2122
- Email: mark.hamilton@ifopa.org
Luoghi di studio
-
-
Missouri
-
North Kansas City, Missouri, Stati Uniti, 064116
- Reclutamento
- The International Fibrodysplasia Ossificans Progressiva Association (IFOPA)
-
Contatto:
- Sammi Kile, MS
- Numero di telefono: 1-720-341-6999
- Email: registry@ifopa.org
-
Contatto:
- Mark Hamilton, PhD
- Numero di telefono: 1-203-605=2122
- Email: mark.hamilton@ifopa.org
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Bambino
- Adulto
- Adulto più anziano
Accetta volontari sani
Sessi ammissibili allo studio
Metodo di campionamento
Popolazione di studio
Individuals with Fibrodysplasia Ossificans Progressive (FOP) from the international FOP community will be invited to join the Registry.
Descrizione
Inclusion Criteria:
- Participants must have a confirmed diagnosis of FOP.
- Participants (or a parent or legal guardian) must be willing and able to provide written informed consent.
Exclusion Criteria:
- There are no exclusion criteria.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Modelli osservazionali: OTHER
- Prospettive temporali: PROSPECTIVE
Coorti e interventi
Gruppo / Coorte |
|---|
|
FOP Patients
None. IFOPA-REG-001 is a FOP patient observational registry study. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Patient Reported Changes in New Bone Growth Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report changes in new bone growth among 27 joints and body locations. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Episodic Flare-Ups Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report changes in episodic flare-ups among 27 joints and body locations. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Mobility Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report changes in mobility among 27 joints and body locations. |
Baseline, then every six months for up to 10 years
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Patient Reported Changes in Health Resource Utilization Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The number of visits to a Physician and a Dentist, as well as the number of hospitalizations and reasons for the hospitalizations, are used to assess health resource utilization. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Ear Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the ears. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Skin Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the skin. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Central Nervous System Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the central nervous system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Pulmonary System Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the pulmonary system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Gastrointestinal System Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the gastrointestinal system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Cardiovascular System Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the cardiovascular system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Renal System Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the renal system. |
Baseline, then every six months for up to 10 years
|
|
Patient Reported Changes in Signs Related to the Endocrine System Using a Patient-Directed Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to report new or continuing health issues related to the endocrine system. |
Baseline, then every six months for up to 10 years
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
I pazienti hanno riferito cambiamenti nelle attività della vita quotidiana utilizzando il questionario FOP sul funzionamento fisico (PFQ)
Lasso di tempo: Basale, poi ogni sei mesi fino a 10 anni
|
Basale, poi ogni sei mesi fino a 10 anni
|
|
|
Il paziente ha riportato cambiamenti nella salute generale utilizzando la scala di salute globale PROMIS
Lasso di tempo: Basale, poi ogni sei mesi fino a 10 anni
|
Basale, poi ogni sei mesi fino a 10 anni
|
|
|
Patient Reported Changes in the Need for Assistive Devices, Aids, Attendants, and Adaptations Using a Survey Developed by the IFOPA
Lasso di tempo: Baseline, then every six months for up to 10 years
|
The patient is able to respond Yes or No to questions related to his/her need for Assistive Devices, Aids, Attendants, and Adaptations as a result of his/her FOP disease. |
Baseline, then every six months for up to 10 years
|
Collaboratori e investigatori
Investigatori
- Direttore dello studio: Mark Hamilton, PhD, International Fibrodysplasia Ossificans Progressiva Association
Pubblicazioni e link utili
Collegamenti utili
- <p>Click here for more information about this study: The FOP Connection Registry</p>
- <p>The International FOP Association is a 501(c)(3) non-profit organization supporting medical research, education and communication for those afflicted by the rare genetic condition Fibrodysplasia Ossificans Progressiva (FOP).</p>
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stimato)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
- Storia Naturale
- Mobilità
- Risultati riferiti dal paziente
- Alluce valgo
- Registro dei pazienti
- Giunto
- FOP
- Fibrodisplasia ossificante progressiva
- Associazione Internazionale FOP
- Gruppo di difesa dei pazienti
- Database osservativo
- Proteina morfogenetica ossea
- BMP
- Crescita ossea
- Divampare
- Ossificazione eterotopica
- Osso ectopico
- Osteocondroma
- ALK2
- ACVR1
- Activina A
- IFOPA
- Recettore dell'attivina A di tipo I
- Kinasi-2 simile al recettore dell'attivina
Termini MeSH pertinenti aggiuntivi
- Malattie ossee
- Malattie muscoloscheletriche
- Malattie muscolari
- Processi patologici
- Neoplasie
- Neoplasie per tipo istologico
- Neoplasie, Connettivo e Tessuto Molle
- Neoplasie, tessuto osseo
- Neoplasie, tessuto connettivo
- Osteocondrodisplasie
- Malattie ossee, dello sviluppo
- Miosite
- Deformità del piede
- Condizioni patologiche, segni e sintomi
- Osteocondroma
- Miosite ossificante
- Alluce valgo
- Ossificazione, eterotopico
Altri numeri di identificazione dello studio
- IFOPA-REG-001
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Formal data sharing agreements are planned between the International FOP Association and biopharmaceutical companies doing research in Fibrodysplasia Ossificans Progressiva (FOP). Publications are also planned with biopharmaceutical companies and physician researchers.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .